Susan E. Barrowcliffe - Net Worth and Insider Trading
Susan E. Barrowcliffe Net Worth
The estimated net worth of Susan E. Barrowcliffe is at least $323,344 dollars as of 2025-05-20. Susan E. Barrowcliffe is the General Manager, Europe of Aimmune Therapeutics Inc and owns about 9,375 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $323,344. Details can be seen in Susan E. Barrowcliffe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Susan E. Barrowcliffe has not made any transactions after 2018-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Susan E. Barrowcliffe
Susan E. Barrowcliffe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Susan E. Barrowcliffe owns 1 companies in total, including Aimmune Therapeutics Inc (AIMT) .
Click here to see the complete history of Susan E. Barrowcliffe’s form 4 insider trades.
Insider Ownership Summary of Susan E. Barrowcliffe
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2018-11-19 | General Manager & Europe |
Susan E. Barrowcliffe Latest Holdings Summary
Susan E. Barrowcliffe currently owns a total of 1 stock. Susan E. Barrowcliffe owns 9,375 shares of Aimmune Therapeutics Inc (AIMT) as of November 19, 2018, with a value of $323,344.
Latest Holdings of Susan E. Barrowcliffe
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AIMT | Aimmune Therapeutics Inc | 2018-11-19 | 9,375 | 34.49 | 323,344 |
Holding Weightings of Susan E. Barrowcliffe
Susan E. Barrowcliffe Form 4 Trading Tracker
According to the SEC Form 4 filings, Susan E. Barrowcliffe has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the sale of 40,000 shares on November 19, 2018, which brought Susan E. Barrowcliffe around $1 Million.
Insider Trading History of Susan E. Barrowcliffe
- 1
Susan E. Barrowcliffe Trading Performance
Susan E. Barrowcliffe Ownership Network
Ownership Network List of Susan E. Barrowcliffe
Ownership Network Relation of Susan E. Barrowcliffe
Susan E. Barrowcliffe Owned Company Details
What does Aimmune Therapeutics Inc do?
Who are the key executives at Aimmune Therapeutics Inc?
Susan E. Barrowcliffe is the General Manager & Europe of Aimmune Therapeutics Inc. Other key executives at Aimmune Therapeutics Inc include 10 percent owner Societe Des Produits Nestle S.a. , Chief Financial Officer Eric Bjerkholt , and Chief Medical Officer Adelman Daniel C Md .
Aimmune Therapeutics Inc (AIMT) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aimmune Therapeutics Inc (AIMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aimmune Therapeutics Inc (AIMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aimmune Therapeutics Inc (AIMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aimmune Therapeutics Inc Insider Transactions
Susan E. Barrowcliffe Mailing Address
Above is the net worth, insider trading, and ownership report for Susan E. Barrowcliffe. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Susan E. Barrowcliffe's mailing address is: Suite 300 Brisbane Ca 94005-1884.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
